Teva's market cap is currently 73.86B. The company's EPS TTM is 222.8; its P/E ratio is ―; Teva is scheduled to report earnings on July 30, 2025, and the estimated EPS forecast is 224.20. See an overview of income statement, balance sheet, and cash flow financials.
